HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Norton Selected Research

hematide

1/2010A subchronic murine intravenous pharmacokinetic and toxicity study of Hematide™, a PEGylated peptidic erythropoiesis-stimulating agent.
2/2009Chronic pharmacological and safety evaluation of Hematide, a PEGylated peptidic erythropoiesis-stimulating agent, in rodents.
9/2008Chronic preclinical safety evaluation of Hematide, a pegylated peptidic erythropoiesis stimulating agent in monkeys.
1/2008Preclinical safety and pharmacology of Hematide, a peptidic erythropoiesis stimulating agent (ESA), in rats and monkeys.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel Norton Research Topics

Disease

4Polycythemia (Erythrocytosis)
01/2010 - 01/2008
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2017
1Hyperplasia
01/2010
1Chronic Kidney Failure (Chronic Renal Failure)
02/2009
1Anemia
09/2008
1Mental Disorders (Mental Disorder)
11/2006
1Schizophrenia (Dementia Praecox)
11/2006

Drug/Important Bio-Agent (IBA)

4hematideIBA
01/2010 - 01/2008
2HematinicsIBA
02/2009 - 09/2008
2Peptides (Polypeptides)IBA
02/2009 - 09/2008
1Antiparasitic Agents (Antiparasitics)IBA
01/2017
1nitazoxanide (NTZ)FDA Link
01/2017
1Biomarkers (Surrogate Marker)IBA
11/2006